Continuous Glucose Monitoring Market Scope And Analysis

  • Report Code : TIPRE00018031
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Continuous Glucose Monitoring Device Market Analysis by 2031

Buy Now

Continuous Glucose Monitoring Device (CGMD) Market Report Continuous Glucose Monitoring Device (CGMD) Market Size and Share Continuous Glucose Monitoring Device (CGMD) Market Scope and Analysis

Continuous Glucose Monitoring Device (CGMD) Market Report Scope

Report Attribute Details
Market size in 2024 12.63 Billion
Market Size by 2031 32.97 Billion
Global CAGR (2024 - 2031) 12.6%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Product
  • Sensors
  • Transmitters
  • Receivers
By Application
  • Type 1 Diabetes and Type 2 Diabetes
By Testing Site
  • Fingertip Testing and Alternate Site Testing
By End User
  • Hospitals & Clinics and Self/Homecare
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • B Braun SE
  • F Hoffmann La Roche Ltd
  • LifeScan Inc
  • Medtronic
  • Abbott Laboratories
  • Ypsomed Holding AG
  • Sensionics
  • Nipro Corp
  • GE Healthcare
  • Terumo Corp
    		•